Literature DB >> 26238629

Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.

Seok-In Hong1, Shin Ahn2, Yoon-Seon Lee1, Won Young Kim1, Kyung Soo Lim1, Jae Ho Lee1, Jae-Lyun Lee3.   

Abstract

PURPOSE: This study was performed to measure the incidence and identify potential predictors of contrast-induced nephropathy (CIN) in cancer patients without chronic kidney disease and with normal or near-normal baseline serum creatinine measures who underwent contrast-enhanced computed tomography (CECT). Severity of CIN was reported based on the RIFLE (risk, injury, failure, loss of kidney function, and end-stage renal disease) classification of acute kidney injury.
METHODS: A retrospective analysis was performed on 820 cancer patients who presented at our emergency department from October 2014 to March 2015. CIN was defined as an increase in creatinine concentration of ≥0.5 mg/dL or ≥25 % above baseline that occurred 48 to 72 h after CECT.
RESULTS: The incidence of CIN was 8.0%. Serial CT examination [odds ratio (OR) 4.09; 95% confidence interval (CI) 1.34-12.56], hypotension before the CT scan (OR 3.95; 95% CI 1.77-8.83), liver cirrhosis (OR 2.82; 95% CI 1.06-7.55), BUN/creatinine >20 (OR 2.54; 95% CI 1.44-4.46), and peritoneal carcinomatosis (OR 1.75; 95% CI 1.01-3.00) were independently associated with CIN. Of 66 CIN patients, 44 met any of the severity criteria of the RIFLE classification. Five of these patients died during hospitalization but only one death was related to renal failure.
CONCLUSIONS: Even when the baseline serum creatinine is ≤1.5 mg/dL, a significant portion of cancer patients are still at risk of CIN. Consecutive CECT examinations, hypotension before CT, liver cirrhosis, dehydration, and peritoneal carcinomatosis seem to predispose patients to CIN.

Entities:  

Keywords:  Cancer; Computed tomography; Contrast-induced nephropathy; Serum creatinine

Mesh:

Substances:

Year:  2015        PMID: 26238629     DOI: 10.1007/s00520-015-2875-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  30 in total

1.  Incidence of renal insufficiency in cancer patients.

Authors:  Ekrem Dogan; Mustafa Izmirli; Kadir Ceylan; Reha Erkoc; Hayriye Sayarlioglu; Huseyin Begenik; Suleyman Alici
Journal:  Adv Ther       Date:  2005 Jul-Aug       Impact factor: 3.845

2.  Incidence and predictors of contrast-induced nephropathy following CT-angiography for clinically suspected acute pulmonary embolism.

Authors:  J Kooiman; F A Klok; I C M Mos; A van der Molen; A de Roos; Y W J Sijpkens; M V Huisman
Journal:  J Thromb Haemost       Date:  2009-11-23       Impact factor: 5.824

3.  Contrast-induced nephropathy risk due to emergency contrast-enhanced computed tomography.

Authors:  Polat Durukan; Seda Ozkan; Ibrahim Ikizceli; Alper Vardar; Afsin Ipekci; Ali Duman
Journal:  Eur J Emerg Med       Date:  2012-02       Impact factor: 2.799

4.  Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography.

Authors:  Stephen J Traub; John A Kellum; Aimee Tang; Lauren Cataldo; Adarsh Kancharla; Nathan I Shapiro
Journal:  Acad Emerg Med       Date:  2013-01       Impact factor: 3.451

5.  Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.

Authors:  Eric A J Hoste; Norbert H Lameire; Raymond C Vanholder; Dominique D Benoit; Johan M A Decruyenaere; Francis A Colardyn
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

6.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

7.  Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.

Authors:  Richard J Owen; Swapnil Hiremath; Andy Myers; Margaret Fraser-Hill; Brendan J Barrett
Journal:  Can Assoc Radiol J       Date:  2014-02-20       Impact factor: 2.248

Review 8.  Acute kidney injury with iodinated contrast.

Authors:  Peter A McCullough
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

9.  Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.

Authors:  Vincent Launay-Vacher; Stéphane Oudard; Nicolas Janus; Joseph Gligorov; Xavier Pourrat; Olivier Rixe; Jean-François Morere; Philippe Beuzeboc; Gilbert Deray
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

Review 10.  Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence.

Authors:  Swapnil Hiremath; Ayub Akbari; Wael Shabana; Dean A Fergusson; Greg A Knoll
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more
  13 in total

1.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

2.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

Review 3.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

4.  Intravoxel Incoherent Motion of Colon Cancer Liver Metastases for the Assessment of Response to Antiangiogenic Treatment: Results from a Pilot Study.

Authors:  Ayşegül Öz; Sadık Server; Bedriye Koyuncu Sökmen; Esat Namal; Nagihan İnan; Numan Cem Balcı
Journal:  Med Princ Pract       Date:  2020-01-09       Impact factor: 1.927

Review 5.  The Incidence and Associated Risk Factors of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Emergency Setting: A Systematic Review.

Authors:  Mei-Yi Ong; Justin Jie-Hui Koh; Suchart Kothan; Christopher Lai
Journal:  Life (Basel)       Date:  2022-06-01

Review 6.  Contrast-Enhanced Abdominal MRI for Suspected Appendicitis: How We Do It.

Authors:  Sonja Kinner; Michael D Repplinger; Perry J Pickhardt; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-04-11       Impact factor: 3.959

7.  Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.

Authors:  Arwa Nada; Jennifer G Jetton
Journal:  Pediatr Nephrol       Date:  2020-11-27       Impact factor: 3.714

8.  Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.

Authors:  Ketan B Ghaghada; Amy F Sato; Zbigniew A Starosolski; John Berg; David M Vail
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 9.  Acute kidney injury from contrast-enhanced CT procedures in patients with cancer: white paper to highlight its clinical relevance and discuss applicable preventive strategies.

Authors:  Laura Cosmai; Camillo Porta; Carmelo Privitera; Loreto Gesualdo; Giuseppe Procopio; Stefania Gori; Andrea Laghi
Journal:  ESMO Open       Date:  2020-03

10.  Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study.

Authors:  Ismail Altintop; Mehmet Tatli; Cigdem Karakukcu; Zeynep Soyer Sarica; Arzu Hanım Yay; Esra Balcioglu; Ahmet Ozturk
Journal:  Medicina (Kaunas)       Date:  2018-07-30       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.